Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy.
Fumet, Jean-David; Richard, Corentin; Ledys, Fanny; Klopfenstein, Quentin; Joubert, Philippe; Routy, Bertrand; Truntzer, Caroline; Gagné, Andréanne; Hamel, Marc-André; Guimaraes, Camila Figueiredo; Coudert, Bruno; Arnould, Laurent; Favier, Laure; Lagrange, Aurélie; Ladoire, Sylvain; Saintigny, Pierre; Ortiz-Cuaran, Sandra; Perol, Maurice; Foucher, Pascal; Hofman, Paul; Ilie, Marius; Chevrier, Sandy; Boidot, Romain; Derangere, Valentin; Ghiringhelli, François.
Br J Cancer
; 119(8): 950-960, 2018 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-30318514
Prognostic implication of programmed cell death 1 protein and its ligand expressions in endometrial cancer.
[Impact of PD-L1 status on the long-term outcomes of radical treatment of patients with prostate cancer].
Prognostic significance of PD-L1 expression on circulating tumor cells in patients with head and neck squamous cell carcinoma.
The Immune Checkpoint Regulator PD-L1 Is Highly Expressed in Aggressive Primary Prostate Cancer.
B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes.
PD-L1 protein expression assessed by immunohistochemistry is neither prognostic nor predictive of benefit from adjuvant chemotherapy in resected non-small cell lung cancer.
Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma - correlation with clinicopathological data and comparison of antibodies.
Prognostic effect of programmed death-ligand 1 (PD-L1) in ovarian cancer: a systematic review, meta-analysis and bioinformatics study.
PROGRAMMED CELL DEATH-LIGAND 1 OVEREXPRESSION IN THYROID CANCER.
Frequencies and expression levels of programmed death ligand 1 (PD-L1) in circulating tumor RNA (ctRNA) in various cancer types.